SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000045
Filing Date
2023-09-11
Accepted
2023-09-11 16:27:56
Documents
12
Period of Report
2023-09-07
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20230907.htm   iXBRL 8-K 24601
  Complete submission text file 0001396814-23-000045.txt   150663

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20230907.xsd EX-101.SCH 1911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20230907_lab.xml EX-101.LAB 24134
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20230907_pre.xml EX-101.PRE 12518
6 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20230907_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 231248073
SIC: 2834 Pharmaceutical Preparations